Sanjay Shukla, President and CEO at aTYR PHARMA INC (LIFE), bought 15,000 shares at $1.18 ($18K) on 2023-12-12, disclosed to the SEC on 2023-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 3,000 | $4K | 19.9% |
| 2 | $1.18 | 12,000 | $14K | 80.1% |
| Total | $1.18 avg | 15,000 | $18K | 100% |
| Filing → |
| LIFE | BUY | 2023-11-13 | $17K | — | Filing → |
| LIFE | BUY | 2023-08-01 | $30K | — | Filing → |
| LIFE | BUY | 2022-11-21 | $21K | — | Filing → |